Table 3.
Antibody | GBS total | MFv total | Total |
---|---|---|---|
GD1a | 3 (33.3%) | 2 (25%) | 5 (29.4%) |
GD1b | 5 (55.5%) | 2 (25%) | 7 (41.2%) |
GQ1b | 2 (22.2%) | 4 (50%) | 6 (35.3%) |
AsialoGM1 | 2 (22.2%) | 1 (12.5%) | 3 (17.6%) |
GM1 | 4 (44.4%) | 0 | 4 (23.5%) |
GM2 | 2 (22.2%) | 0 | 2 (11.8%) |
Summary of ganglioside antibody panel for 17 patients diagnosed with GBS and MFv in Adventist Health White Memorial (AHWM) and California Hospital Medical Center (CHMC) in 2015.